Nick Abbott

Stock Analyst at Wells Fargo

(0.05)
# 4,149
Out of 4,820 analysts
6
Total ratings
20%
Success rate
-36.09%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Nick Abbott

Zymeworks
Oct 4, 2022
Assumes: Overweight
Price Target: $45$9
Current: $12.57
Upside: -28.40%
Alaunos Therapeutics
Oct 4, 2022
Assumes: Overweight
Price Target: $450
Current: $2.63
Upside: +17,010.27%
Adaptimmune Therapeutics
Oct 4, 2022
Maintains: Equal-Weight
Price Target: $7$1.5
Current: $0.26
Upside: +468.18%
Cellectis
Jan 6, 2022
Downgrades: Equal-Weight
Price Target: $16
Current: $1.55
Upside: +932.26%
Affimed
Mar 24, 2021
Maintains: Overweight
Price Target: $100$150
Current: $0.96
Upside: +15,508.74%